Randomized Population-Based Study on Chlamydia Trachomatis Screening
30,000 individuals living in Aarhus County, Denmark by Oct 1997 were randomized into two groups. The intervention group received an invitation to be tested for urogenital Chlamydia trachomatis by use of home-obtained and mailed sample (9,000 individuals). The control group received no intervention (21,000 individuals). Outcome measures: Number of tested individuals, number of detected infections, number of women developing PID, ectopic pregnancy or infertility, number of women giving birth to a child, number of women receiving IVF treatment and number of men developing epididymitis.
The hypothesis was that more individuals would be tested and treated for infections and that number of long term fertility complications would decline in the intervention group compared to control group.
|Chlamydia Trachomatis Infertility Ectopic Pregnancy||Behavioral: Screening for urogenital Chlamydia trachomatis|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Screening
|Official Title:||Populationbased Screening for Urogenital Chlamydia Trachomatis Infections by Use of Home-Obtained and Mailed Samples: A Randomized Study|
- Long term infertility complications [ Time Frame: 2008 ]
|Study Start Date:||October 1997|
|Study Completion Date:||August 2007|
|Primary Completion Date:||February 1998 (Final data collection date for primary outcome measure)|
Experimental: 1 Screening
Individuals receiving an invitation to be tested for urogenital Chlamydia trachomatis by use of a home-obtained and mailed sample.
Behavioral: Screening for urogenital Chlamydia trachomatis
Receeiving an invitation to be tested for urogenital Chlamydia trachomatis by use of a home-obtained and mailed sample.
No Intervention: 2 Control
Control group receiving usual care
Please refer to this study by its ClinicalTrials.gov identifier: NCT00827970
|Department of Infectious Diseases, Aarhus University Hospital Skejby|
|Aarhus N, Denmark, 8200|
|Principal Investigator:||Berit Andersen, MD, Ph.D.||Aarhus University Hospital Skejby, Department of Infectious Diseases|